![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears Pulse Biosciences’ Cell FX System
FDA Clears Pulse Biosciences’ Cell FX System
![FDA clears text](https://www.fdanews.com/ext/resources/test/Drug-Images4/FDA-clears.gif?t=1619732616&width=430)
February 5, 2021
The FDA has granted Hayward, Calif.-based Pulse Biosciences 510(k) marketing clearance for its Cell FX, a nano-pulse stimulation device used for skin-ablation procedures.
The CellFX system delivers nano-second pulses of electrical energy to clear unwanted cellular structures while avoiding damage to surrounding healthy skin.
The company said it will begin a commercial launch of the nano-pulse stimulation system in the U.S. “in the coming weeks.” The system, which recently earned CE mark certification, is already available in Europe.
Upcoming Events
-
21Oct